Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Inks National Coverage Agreement with UnitedHealthcare for Prenatal Dx

NEW YORK (GenomeWeb) – Sequenom has secured a national coverage agreement with UnitedHealthcare for its prenatal diagnostic tests.

The agreement covers Sequenom's noninvasive prenatal test, MaterniT21 Plus and also its universal and cystic fibrosis carrier screening tests, HerediT Universal and HerediT CF. It will go into effect Oct. 1 and will cover 43 million people throughout the US.

Including the agreement with UnitedHealthcare, Sequenom now has more than 200 million lives covered under contract.

The agreement does not include Sequenom's newer offerings — its VisibiliT test for screening women with average-risk pregnancies for trisomies 21 and 18; or its MaterniT Genome, a noninvasive test that analyzes chromosomal loss or duplication of greater than 7 megabases across the entire genome. 

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.